Hematopoietic Cell Transplantation Clinical Trial
Official title:
Prospective Multi Center Study of Pediatric Cellular Therapy Patients at Risk for Endothelial Dysfunction, Sinusoidal Obstruction Syndrome and/or Multi-Organ Dysfunction Syndrome (MODS)
This is a prospective international multi-center registry and biorepository trial of children and adolescents/young adults (AYA) undergoing hematopoietic cell transplantation (HCT) to assess the impact of endotheliopathies in the HCT setting as a contributor of significant morbidity and mortality.
Primary: - To evaluate the proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who develop endotheliopathies (SOS, TMA, DAH and IPS) and/or MODS within 100 days of such therapies. - To evaluate the proportion of pediatric patients undergoing hematopoietic cell transplant (HCT) who experience abnormal levels of circulating angiogenic, vascular permeability and inflammatory factors within 100 days post HCT-CT in the setting of endotheliopathies. Secondary/Exploratory Objective(s): - To determine the impact of endotheliopathies in the HCT setting on the overall survival. - To assess the efficacy of specific prophylaxis and treatment strategies directed at endotheliopathies (SOS, TMA, DAH and IPS) post-HCT among enrolled children on overall survival. - To assess whether exposure to immunotherapies (CAR-T, PD-1 Inhibitors, bispecific T-cell engager (BiTE) antibodies and antibody drug conjugates) prior to HCT affects post-HCT outcomes (endotheliopathies and MODS). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03179761 -
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
|
Phase 2 | |
Recruiting |
NCT05634512 -
Evaluation of Intravenous Laronidase Pharmacokinetics Before and After Hematopoietic Cell Transplantation in Patients With Mucopolysaccharidosis Type IH.
|
||
Completed |
NCT05600101 -
Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT05866302 -
Parametric Response Mapping (PRM) for the Detection of Chronic Lung Injury in Hematopoietic Cell Transplant Recipients
|
||
Completed |
NCT04139577 -
FMT In High-Risk Acute GVHD After ALLO HCT
|
Phase 1 | |
Completed |
NCT04727827 -
Pharmacogenomic-Guided Supportive Care in Hematopoietic Cell Transplantation
|
N/A |